Skip to main content
Erschienen in: World Journal of Surgery 6/2016

21.01.2016 | Original Scientific Report

Cholecystectomy Causes Ultrasound Evidence of Increased Hepatic Steatosis

verfasst von: Sangchul Yun, Dongho Choi, Kyeong Geun Lee, Han Joon Kim, Bo-Kyeong Kang, Hyunsung Kim, Seung Sam Paik

Erschienen in: World Journal of Surgery | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Cholecystectomy might contribute to the development of hepatic steatosis through metabolic changes. The biologic alteration of the enterohepatic circulation of bile acids and the alteration of the metabolic activity of bile acid that follows cholecystectomy may contribute to hepatic steatosis. This prospective study was conducted to clarify the possibility of steatosis development after cholecystectomy.

Methods

From October 2013 to July 2014, 82 consecutive patients with a presumptive diagnosis of gallbladder disease were cholecystectomized. Liver parenchymal steatosis was measured using ultrasound and the hepatic steatosis index.

Results

In all 82 patients, the hepatic steatosis index was found to be significantly correlated with the US fatty liver grade (Spearman’s correlation r 2 = 0.331, P < 0.001). A total of 62 patients were followed up for 3 months. Comparison with the initial grade showed that 12 (18.5 %) patients had worsened from normal to mild (n = 10), from mild to moderate (n = 1), and from mild to severe (n = 1). The other patients stayed at their initial grade except one patient who improved (from moderated to mild). Analysis of laboratory findings showed that white blood cell count, aspartate transaminase, alanine transaminase level, and total bilirubin level were decreased. However, serum albumin and high-density lipoprotein cholesterol levels significantly increased.

Conclusions

Hepatic steatosis significantly developed 3 months after cholecystectomy. Therefore, cholecystectomy might be considered a risk factor for hepatic steatosis, but the relationship should be confirmed with long-term follow-up from a large group of patients.
Literatur
1.
Zurück zum Zitat Chen LY, Qiao QH, Zhang SC et al (2012) Metabolic syndrome and gallstone disease. World J Gastroenterol WJG 18:4215–4220CrossRefPubMed Chen LY, Qiao QH, Zhang SC et al (2012) Metabolic syndrome and gallstone disease. World J Gastroenterol WJG 18:4215–4220CrossRefPubMed
2.
Zurück zum Zitat Lockman KA, Nyirenda MJ (2010) Interrelationships between hepatic fat and insulin resistance in non-alcoholic fatty liver disease. Curr Diabetes Rev 6:341–347CrossRefPubMed Lockman KA, Nyirenda MJ (2010) Interrelationships between hepatic fat and insulin resistance in non-alcoholic fatty liver disease. Curr Diabetes Rev 6:341–347CrossRefPubMed
3.
Zurück zum Zitat Loria P, Lonardo A, Lombardini S et al (2005) Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 20:1176–1184CrossRefPubMed Loria P, Lonardo A, Lombardini S et al (2005) Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 20:1176–1184CrossRefPubMed
4.
Zurück zum Zitat Ramos-De la Medina A, Remes-Troche JM, Roesch-Dietlen FB et al (2008) Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified? J Gastrointest Surg 12:2097–2102 (Discussion 2102)CrossRefPubMed Ramos-De la Medina A, Remes-Troche JM, Roesch-Dietlen FB et al (2008) Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified? J Gastrointest Surg 12:2097–2102 (Discussion 2102)CrossRefPubMed
5.
Zurück zum Zitat Koller T, Kollerova J, Hlavaty T et al (2012) Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol 47:197–203CrossRefPubMed Koller T, Kollerova J, Hlavaty T et al (2012) Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol 47:197–203CrossRefPubMed
6.
Zurück zum Zitat Nervi F, Miquel JF, Alvarez M et al (2006) Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. J Hepatol 45:299–305CrossRefPubMed Nervi F, Miquel JF, Alvarez M et al (2006) Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. J Hepatol 45:299–305CrossRefPubMed
7.
Zurück zum Zitat Bellentani S, Saccoccio G, Masutti F et al (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132:112–117CrossRefPubMed Bellentani S, Saccoccio G, Masutti F et al (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132:112–117CrossRefPubMed
8.
Zurück zum Zitat Ruhl CE, Everhart JE (2013) Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol 108:952–958CrossRefPubMed Ruhl CE, Everhart JE (2013) Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol 108:952–958CrossRefPubMed
9.
Zurück zum Zitat Ioannou GN (2010) Cholelithiasis, cholecystectomy, and liver disease. Am J Gastroenterol 105:1364–1373CrossRefPubMed Ioannou GN (2010) Cholelithiasis, cholecystectomy, and liver disease. Am J Gastroenterol 105:1364–1373CrossRefPubMed
10.
Zurück zum Zitat Kullak-Ublick GA, Paumgartner G, Berr F (1995) Long-term effects of cholecystectomy on bile acid metabolism. Hepatology 21:41–45CrossRefPubMed Kullak-Ublick GA, Paumgartner G, Berr F (1995) Long-term effects of cholecystectomy on bile acid metabolism. Hepatology 21:41–45CrossRefPubMed
11.
Zurück zum Zitat Zweers SJ, Booij KA, Komuta M et al (2012) The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology 55:575–583CrossRefPubMed Zweers SJ, Booij KA, Komuta M et al (2012) The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology 55:575–583CrossRefPubMed
12.
Zurück zum Zitat Amigo L, Husche C, Zanlungo S et al (2011) Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice. Liver Int 31:52–64CrossRefPubMed Amigo L, Husche C, Zanlungo S et al (2011) Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice. Liver Int 31:52–64CrossRefPubMed
13.
Zurück zum Zitat Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142:1592–1609CrossRefPubMed Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142:1592–1609CrossRefPubMed
14.
15.
Zurück zum Zitat Lee JH, Kim D, Kim HJ et al (2010) Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 42:503–508CrossRefPubMed Lee JH, Kim D, Kim HJ et al (2010) Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 42:503–508CrossRefPubMed
16.
Zurück zum Zitat Lazo M, Hernaez R, Bonekamp S et al (2011) Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 343:d6891CrossRefPubMedPubMedCentral Lazo M, Hernaez R, Bonekamp S et al (2011) Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 343:d6891CrossRefPubMedPubMedCentral
17.
18.
Zurück zum Zitat Matsuzawa N, Takamura T, Kurita S et al (2007) Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46:1392–1403CrossRefPubMed Matsuzawa N, Takamura T, Kurita S et al (2007) Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46:1392–1403CrossRefPubMed
19.
Zurück zum Zitat Wouters K, van Gorp PJ, Bieghs V et al (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48:474–486CrossRefPubMed Wouters K, van Gorp PJ, Bieghs V et al (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48:474–486CrossRefPubMed
20.
Zurück zum Zitat Ioannou GN, Morrow OB, Connole ML et al (2009) Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology 50:175–184CrossRefPubMed Ioannou GN, Morrow OB, Connole ML et al (2009) Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology 50:175–184CrossRefPubMed
21.
Zurück zum Zitat Wang DQ, Lee SP (2008) Physical chemistry of intestinal absorption of biliary cholesterol in mice. Hepatology 48:177–185CrossRefPubMed Wang DQ, Lee SP (2008) Physical chemistry of intestinal absorption of biliary cholesterol in mice. Hepatology 48:177–185CrossRefPubMed
22.
Zurück zum Zitat Almond HR, Vlahcevic ZR, Bell CC Jr et al (1973) Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy. New Engl J Med 289:1213–1216CrossRefPubMed Almond HR, Vlahcevic ZR, Bell CC Jr et al (1973) Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy. New Engl J Med 289:1213–1216CrossRefPubMed
23.
Zurück zum Zitat Shaffer EA, Small DM (1977) Biliary lipid secretion in cholesterol gallstone disease: the effect of cholecystectomy and obesity. J Clin Investig 59:828–840CrossRefPubMedPubMedCentral Shaffer EA, Small DM (1977) Biliary lipid secretion in cholesterol gallstone disease: the effect of cholecystectomy and obesity. J Clin Investig 59:828–840CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Eren F, Kurt R, Ermis F et al (2012) Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease. Clin Biochem 45:655–658CrossRefPubMed Eren F, Kurt R, Ermis F et al (2012) Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease. Clin Biochem 45:655–658CrossRefPubMed
26.
27.
Zurück zum Zitat Holt JA, Luo G, Billin AN et al (2003) Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17:1581–1591CrossRefPubMedPubMedCentral Holt JA, Luo G, Billin AN et al (2003) Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17:1581–1591CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Kim I, Ahn SH, Inagaki T et al (2007) Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48:2664–2672CrossRefPubMed Kim I, Ahn SH, Inagaki T et al (2007) Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48:2664–2672CrossRefPubMed
29.
Zurück zum Zitat Tomlinson E, Fu L, John L et al (2002) Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143:1741–1747CrossRefPubMed Tomlinson E, Fu L, John L et al (2002) Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143:1741–1747CrossRefPubMed
30.
Zurück zum Zitat Abu-Elheiga L, Matzuk MM, Abo-Hashema KA et al (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613–2616CrossRefPubMed Abu-Elheiga L, Matzuk MM, Abo-Hashema KA et al (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613–2616CrossRefPubMed
31.
Zurück zum Zitat Wang HG, Wang LZ, Fu HJ et al (2015) Cholecystectomy does not significantly increase the risk of fatty liver disease. World J Gastroenterol WJG 21:3614–3618CrossRefPubMed Wang HG, Wang LZ, Fu HJ et al (2015) Cholecystectomy does not significantly increase the risk of fatty liver disease. World J Gastroenterol WJG 21:3614–3618CrossRefPubMed
32.
Zurück zum Zitat Hamaguchi M, Kojima T, Itoh Y et al (2007) The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 102:2708–2715CrossRefPubMed Hamaguchi M, Kojima T, Itoh Y et al (2007) The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 102:2708–2715CrossRefPubMed
Metadaten
Titel
Cholecystectomy Causes Ultrasound Evidence of Increased Hepatic Steatosis
verfasst von
Sangchul Yun
Dongho Choi
Kyeong Geun Lee
Han Joon Kim
Bo-Kyeong Kang
Hyunsung Kim
Seung Sam Paik
Publikationsdatum
21.01.2016
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 6/2016
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-015-3396-7

Weitere Artikel der Ausgabe 6/2016

World Journal of Surgery 6/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.